{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:27:25Z","timestamp":1790832445518,"version":"4.1.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01880","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T04:50:30Z","timestamp":1597812630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":62,"title":["The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development"],"prefix":"10.3389","volume":"11","author":[{"given":"Sana O.","family":"Alturki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan O.","family":"Alturki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Cusimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele A.","family":"Kutzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Izmirly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias K.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1401505","article-title":"Evidence for camel-to-human transmission of MERS coronavirus","volume":"370","author":"Azhar","year":"2014","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1099\/vir.0.82220-0","article-title":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis","volume":"87","author":"Ren","year":"2006","journal-title":"J Gen Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cll.2009.07.007","article-title":"Recently discovered human coronaviruses","volume":"29","author":"Wevers","year":"2009","journal-title":"Clin Lab Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol."},{"key":"B9","unstructured":"WHO Director-General's Remarks at the Media Briefing on 2019-nCoV on 11 February 20202020"},{"key":"B10","doi-asserted-by":"crossref","unstructured":"Coronavirus Disease(COVID-19) Situation Report \u2013 155.2020","DOI":"10.17265\/1537-1506\/2020.03.002"},{"key":"B11","unstructured":"Coronavirus Disease 2019 (COVID-19).2020"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/CM9.0000000000000722","article-title":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study","volume":"133","author":"Ren","year":"2020","journal-title":"Chinese Med J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2139\/ssrn.3544840","article-title":"Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study","volume":"77","author":"Mao","year":"2020","journal-title":"BMJ."},{"key":"B15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet."},{"key":"B17","doi-asserted-by":"crossref","unstructured":"Q&A: Similarities and Differences \u2013 COVID-19 and Influenza.2020","DOI":"10.1101\/2021.01.02.21249125"},{"key":"B18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.46234\/ccdcw2020.017","article-title":"A novel coronavirus genome identified in a cluster of pneumonia cases\u2014Wuhan, China 2019\u20132020","volume":"2","author":"Tan","year":"2020","journal-title":"China CDC Wkly."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"P7","DOI":"10.1164\/rccm.2014P7","article-title":"Novel Wuhan (2019-nCoV) coronavirus","volume":"201","author":"Carlos","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"105730","DOI":"10.1016\/j.envint.2020.105730","article-title":"Airborne transmission of SARS-CoV-2: the world should face the reality","volume":"139","author":"Morawska","year":"2020","journal-title":"Environ Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1","volume":"382","author":"van Doremalen","year":"2020","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","article-title":"Temporal dynamics in viral shedding and transmissibility of COVID-19","volume":"26","author":"He","year":"2020","journal-title":"Nat Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell."},{"key":"B26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3390\/v6082991","article-title":"The coronavirus nucleocapsid is a multifunctional protein","volume":"6","author":"McBride","year":"2014","journal-title":"Viruses."},{"key":"B28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","article-title":"A structural analysis of M protein in coronavirus assembly and morphology","volume":"174","author":"Neuman","year":"2011","journal-title":"J Struc Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1004077","DOI":"10.1371\/journal.ppat.1004077","article-title":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis","volume":"10","author":"Nieto-Torres","year":"2014","journal-title":"PLoS Pathogens."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1128\/JVI.02292-10","article-title":"Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques","volume":"85","author":"Liu","year":"2011","journal-title":"J Virol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.1016\/S2666-5247(20)30004-5","article-title":"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study","volume":"1","author":"Chu","year":"2020","journal-title":"Lancet Microbe."},{"key":"B33","doi-asserted-by":"publisher","first-page":"15748","DOI":"10.1073\/pnas.0403812101","article-title":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus","volume":"101","author":"Jeffers","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.14.988345","article-title":"SARS-CoV-2 invades host cells via a novel route: CD147-spike protein","author":"Wang","year":"2020","journal-title":"bioRxiv [Preprint]."},{"key":"B35","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1128\/JVI.05300-11","article-title":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease","volume":"85","author":"Bertram","year":"2011","journal-title":"J Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"11318","DOI":"10.1128\/JVI.01052-08","article-title":"The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles","volume":"82","author":"Siu","year":"2008","journal-title":"J Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature."},{"key":"B39","unstructured":"R&D Blueprint and COVID-19.2020"},{"key":"B40","unstructured":"Codagenix and Serum Institute of India Initiate Co-Development of a Scalable, Live-Attenuated Vaccine Against the 2019 Novel Coronavirus, COVID-19.2020"},{"key":"B41","unstructured":"CheungE China coronavirus: Hong Kong Researchers Have Already Developed Vaccine but Need Time to Test it, Expert Reveals: South China Morning Post.2020"},{"key":"B42","unstructured":"ViroclinicsXplore International Partnership Progresses UQ COVID-19 Vaccine Project.2020"},{"key":"B43","unstructured":"Geovax and Bravovax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine2020"},{"key":"B44","unstructured":"Altimmune Completes First Development Milestone Toward A Single-Dose Intranasal COVID-19 Vaccine.2020"},{"key":"B45","unstructured":"Clover Initiates Development of Recombinant Subunit- Trimer Vaccine for Wuhan Coronavirus (2019-ncov).2020"},{"key":"B46","unstructured":"32571880About CureVac's Activities Regarding an mRNA Based Vaccine Against COVID-19.2020"},{"key":"B47","unstructured":"Novel Coronavirus \u2013 China.2020"},{"key":"B48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Ann Rev Virol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science."},{"key":"B50","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun."},{"key":"B53","unstructured":"Covid-19 Program Vision.2019"},{"key":"B54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13567-017-0437-2","article-title":"Innate immune responses induced by the saponin adjuvant matrix-M in specific pathogen free pigs","volume":"48","author":"Ahlberg","year":"2017","journal-title":"Vet Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.vaccine.2016.02.033","article-title":"Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a zaire ebola\/makona virus glycoprotein (GP) nanoparticle vaccine in mice","volume":"34","author":"Bengtsson","year":"2016","journal-title":"Vaccine."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.vaccine.2013.01.039","article-title":"Immune enhancing properties of the novel matrix-M\u2122 adjuvant leads to potentiated immune responses to an influenza vaccine in mice","volume":"31","author":"Magnusson","year":"2013","journal-title":"Vaccine."},{"key":"B57","unstructured":"Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May Novavax.2020"},{"key":"B58","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet."},{"key":"B59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.coi.2020.01.006","article-title":"DNA vaccines: prime time is now","volume":"65","author":"Gary","year":"2020","journal-title":"Curr Opin Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","article-title":"Immunogenicity of a DNA vaccine candidate for COVID-19","volume":"11","author":"Smith","year":"2020","journal-title":"Nat Commun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"301ra132","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A synthetic consensus anti\u2013spike protein DNA vaccine induces protective immunity against middle east respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci Transl Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41541-020-0188-3","article-title":"COVID-19 vaccines: breaking record times to first-in-human trials","volume":"5","author":"Kim","year":"2020","journal-title":"NPJ Vaccin."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1080\/21645515.2017.1383575","article-title":"Chimpanzee adenoviral vectors as vaccines for outbreak pathogens","volume":"13","author":"Ewer","year":"2017","journal-title":"Hum Vaccin Immunother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"eaba8399","DOI":"10.1101\/2020.04.13.036293","article-title":"A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques","volume":"6","author":"van Doremalen","year":"2020","journal-title":"Science Adv."},{"key":"B65","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1473-3099(20)30160-2","article-title":"Safety and immunogenicity of a candidate middle east respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial","volume":"20","author":"Folegatti","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B66","unstructured":"32295479A Study of a Candidate COVID-19 Vaccine (COV001).2020"},{"key":"B67","unstructured":"COVID-19 Vaccine Development.2020"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(09)61208-3","article-title":"Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials","volume":"374","author":"Prymula","year":"2009","journal-title":"Lancet."},{"key":"B69","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/pch\/pxy011","article-title":"Fever prophylaxis can reduce vaccine responses: a caution","volume":"23","author":"Scheifele","year":"2018","journal-title":"Paediatr Child Health."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e98175","DOI":"10.1371\/journal.pone.0098175","article-title":"Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials","volume":"9","author":"Doed\u00e9e","year":"2014","journal-title":"PloS ONE."},{"key":"B71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41541-020-0163-z","article-title":"Modified mRNA\/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection","volume":"5","author":"Espeseth","year":"2020","journal-title":"NPJ Vaccin."},{"key":"B72","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr Opin Immunol."},{"key":"B73","unstructured":"Moderna Ships mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study.2020"},{"key":"B74","unstructured":"Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19).2020"},{"key":"B75","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fimmu.2016.00354","article-title":"Recent advances in lentiviral vaccines for HIV-1 infection","volume":"7","author":"Norton","year":"2016","journal-title":"Front immunol."},{"key":"B76","unstructured":"Safety and Immunity of Covid-19 aAPC Vaccine.2020"},{"key":"B77","unstructured":"InstituteSGIM Immunity and Safety of Covid-19 Synthetic Minigene Vaccine.2020"},{"key":"B78","unstructured":"Pfizer and Biontech Dose First Participants in the U.S. as Part of Global Covid-19 Mrna Vaccine Development Program2020"},{"key":"B79","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Thanh Le","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"39","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.4161\/hv.29594","article-title":"Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?","volume":"10","author":"Fausther-Bovendo","year":"2014","journal-title":"Hum Vaccin Immunother."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet."},{"key":"B83","volume-title":"Does BCG Vaccination Protect Against Acute Respiratory Infections and COVID-19? A Rapid Review of Current Evidence","author":"Soliman","year":"2020"},{"key":"B84","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe."},{"key":"B85","first-page":"1281","article-title":"The role of the reticuloendothelial system in the host reaction to neoplasia","volume":"21","author":"Old","year":"1961","journal-title":"Cancer Res."},{"key":"B86","volume-title":"Increased Resistance to Virus Infections of Mice Inoculated With BCG (Bacillus calmette-gu\u00e9rin)","author":"Floc'h","year":"1976"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3389\/fimmu.2020.01055","article-title":"Challenges in dengue vaccines development: pre-existing infections and cross-reactivity","volume":"11","author":"Izmirly","year":"2020","journal-title":"Front. Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"S347","DOI":"10.1086\/520581","article-title":"Epitopes required for antibody-dependent enhancement of ebola virus infection","volume":"196","author":"Takada","year":"2007","journal-title":"J infect Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/j.celrep.2018.07.035","article-title":"Antibody-dependent enhancement of ebola virus infection by human antibodies isolated from survivors","volume":"24","author":"Kuzmina","year":"2018","journal-title":"Cell Rep."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e1005817","DOI":"10.1371\/journal.ppat.1005817","article-title":"Antibody-mediated internalization of infectious HIV-1 virions differs among antibody isotypes and subclasses","volume":"12","author":"Tay","year":"2016","journal-title":"PLoS Pathogens."},{"key":"B91","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/rmv.405","article-title":"Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications","volume":"13","author":"Takada","year":"2003","journal-title":"Rev Med Virol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e02015","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular mechanism for antibody-dependent enhancement of coronavirus entry","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3201\/eid1111.040659","article-title":"Neutralizing antibody response and SARS severity","volume":"11","author":"Ho","year":"2005","journal-title":"Emerg Infect Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.micinf.2020.02.006","article-title":"Is COVID-19 receiving ADE from other coronaviruses?","volume":"22","author":"Tetro","year":"2020","journal-title":"Microbes Infect."},{"key":"B96","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41577-020-0321-6","article-title":"The potential danger of suboptimal antibody responses in COVID-19","volume":"20","author":"Iwasaki","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1073\/pnas.0409065102","article-title":"Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses","volume":"102","author":"Yang","year":"2005","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01880\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T17:46:53Z","timestamp":1616953613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01880\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":97,"alternative-id":["10.3389\/fimmu.2020.01880"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01880","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]},"article-number":"1880"}}